Here we go again-blood transfusion kills patients?

JAMA Internal Medicine

Volumn 173, Issue 2, 2013, Pages 139-141

  Carson, Jeffrey L ^a   Hébert, Paul C ^b  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ACUTE HEART INFARCTION; ANEMIA; BLOOD TRANSFUSION; DEATH; DISEASE SEVERITY; HEALTH CARE POLICY; HEMOGLOBIN BLOOD LEVEL; HUMAN; META ANALYSIS (TOPIC); NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW (TOPIC);

BLOOD TRANSFUSION; HUMANS; MYOCARDIAL INFARCTION;

EID: 84873439494     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2855     Document Type: Note

References (13)

1. Chatterjee S, Wetterslev J, Sharma A, Lichstein E, Mukherjee D. Association of blood transfusion with increased mortality in myocardial infarction: a meta-analysis and diversity-adjusted study sequential analysis [published online December 24, 2012]. JAMA Intern Med. 2013;173(2):132-139.
2. Carson JL, Duff A, Poses RM, et al. Effect of anaemia and cardiovascular disease on surgical mortality and morbidity. Lancet. 1996;348(9034):1055-1060. (Pubitemid 26343599)
3. Cooper HA, Rao SV, Greenberg MD, et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am J Cardiol. 2011;108(8):1108-1111.
4. Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med. 2001;345(17):1230-1236. (Pubitemid 34951486)
5. Middelburg RA, Van De Watering LM, Van der Bom JG. Blood transfusions: good or bad? Confounding by indication, an underestimated problem in clinical transfusion research. Transfusion. 2010;50(6):1181-1183.
6. Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials. Lancet. 2001;357(9253):373- 380. (Pubitemid 32128549)
7. MacMahon S, Collins R. Reliable assessment of the effects of treatment on mortality and major morbidity, II: observational studies. Lancet. 2001;357(9254):455-462. (Pubitemid 32156151)
8. Marik PE, Corwin HL. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med. 2008;36(9):2667-2674.
9. Carson JL, Carless PA, Hebert PC. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev. 2012;4:CD002042.
10. Carson JL, Terrin ML, Noveck H, et al; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med. 2011;365(26):2453-2462.
11. Hébert PC, Wells G, Blajchman MA, et al; Transfusion Requirements in Critical Care Investigators; Canadian Critical Care Trials Group. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med. 1999;340(6):409-417. (Pubitemid 29084771)
12. Lacroix J, Hébert PC, Hutchison JS, et al; TRIPICU Investigators; Canadian Critical Care Trials Group; Pediatric Acute Lung Injury and Sepsis Investigators Network. Transfusion strategies for patients in pediatric intensive care units. N Engl J Med. 2007;356(16):1609-1619.
13. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS Randomized Controlled Trial. JAMA. 2010;304(14):1559-1567.